Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-03-13

AUTHORS

Jarkko Johansson, Jussi Hirvonen, Zsófia Lovró, Laura Ekblad, Valtteri Kaasinen, Olli Rajasilta, Semi Helin, Jouni Tuisku, Saija Sirén, Mirka Pennanen, Arvind Agrawal, Roger Crystal, Petri J. Vainio, Hannu Alho, Mika Scheinin

ABSTRACT

Nasal spray formulations of naloxone, a mu-opioid receptor (MOR) antagonist, are currently used for the treatment of opioid overdose. They may have additional therapeutic utility also in the absence of opioid agonist drugs, but the onset and duration of action at brain MORs have been inadequately characterized to allow such projections. This study provides initial characterization of brain MOR availability at high temporal resolution following intranasal (IN) naloxone administration to healthy volunteers in the absence of a competing opioid agonist. Fourteen participants were scanned twice using positron emission tomography (PET) and [11C]carfentanil, a selective MOR agonist radioligand. Concentrations of naloxone in plasma and MOR availability (relative to placebo) were monitored from 0 to 60 min and at 300-360 min post naloxone. Naloxone plasma concentrations peaked at ~20 min post naloxone, associated with slightly delayed development of brain MOR occupancy (half of peak occupancy reached at ~10 min). Estimated peak occupancies were 67 and 85% following 2 and 4 mg IN doses, respectively. The estimated half-life of occupancy disappearance was ~100 min. The rapid onset of brain MOR occupancy by IN naloxone, evidenced by the rapid onset of its action in opioid overdose victims, was directly documented in humans for the first time. The employed high temporal-resolution PET method establishes a model that can be used to predict brain MOR occupancy from plasma naloxone concentrations. IN naloxone may have therapeutic utility in various addictions where brain opioid receptors are implicated, such as gambling disorder and alcohol use disorder. More... »

PAGES

1-7

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41386-019-0368-x

DOI

http://dx.doi.org/10.1038/s41386-019-0368-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112734542

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30867551


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ume\u00e5 University", 
          "id": "https://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Turku PET Centre, University of Turku, Turku, Finland", 
            "Department of Radiation Sciences, Ume\u00e5 University, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Johansson", 
        "givenName": "Jarkko", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Turku", 
          "id": "https://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Turku PET Centre, University of Turku, Turku, Finland", 
            "Department of Radiology, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hirvonen", 
        "givenName": "Jussi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Clinical Research Services Turku - CRST Ltd, Turku, Finland", 
            "Institute of Biomedicine, University of Turku and Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lovr\u00f3", 
        "givenName": "Zs\u00f3fia", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre", 
          "id": "https://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ekblad", 
        "givenName": "Laura", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Division of Clinical Neurosciences, University of Turku and Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaasinen", 
        "givenName": "Valtteri", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Institute of Biomedicine, University of Turku and Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rajasilta", 
        "givenName": "Olli", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre", 
          "id": "https://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Helin", 
        "givenName": "Semi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre", 
          "id": "https://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tuisku", 
        "givenName": "Jouni", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Institute of Biomedicine, University of Turku and Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sir\u00e9n", 
        "givenName": "Saija", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Clinical Research Services Turku - CRST Ltd, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pennanen", 
        "givenName": "Mirka", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Opiant Pharmaceuticals Inc., Santa Monica, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Agrawal", 
        "givenName": "Arvind", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Opiant Pharmaceuticals Inc., Santa Monica, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crystal", 
        "givenName": "Roger", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Institute of Biomedicine, University of Turku and Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vainio", 
        "givenName": "Petri J.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Helsinki University Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.15485.3d", 
          "name": [
            "National Institute for Health and Welfare, Helsinki, Finland", 
            "Abdominal Center, University Hospital of Helsinki, Helsinki, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alho", 
        "givenName": "Hannu", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Clinical Research Services Turku - CRST Ltd, Turku, Finland", 
            "Institute of Biomedicine, University of Turku and Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scheinin", 
        "givenName": "Mika", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1097/01.wcb.0000085441.37552.ca", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002335609", 
          "https://doi.org/10.1097/01.wcb.0000085441.37552.ca"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.wcb.0000085441.37552.ca", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002335609"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jcph.759", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005050213"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuroimage.2006.01.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005818793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archpsyc.62.1.57", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006003582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1192/bjp.bp.106.031120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008044803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuroimage.2011.07.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010720015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.npp.1300790", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016493335", 
          "https://doi.org/10.1038/sj.npp.1300790"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.npp.1300790", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016493335", 
          "https://doi.org/10.1038/sj.npp.1300790"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.npp.1300790", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016493335", 
          "https://doi.org/10.1038/sj.npp.1300790"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)62185-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017818959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)62185-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017818959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/jpet.116.235192", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018917259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-3223(01)01079-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021383326"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0196-0644(83)80343-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022544717"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0196-0644(83)80343-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022544717"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1192/bjp.bp.110.078105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024901521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-008-0935-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026801956", 
          "https://doi.org/10.1007/s00259-008-0935-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-008-0935-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026801956", 
          "https://doi.org/10.1007/s00259-008-0935-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.jcbfm.9600493", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027459113", 
          "https://doi.org/10.1038/sj.jcbfm.9600493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000435876", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027499237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuroimage.2005.02.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028354406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1097/01.wcb.0000033967.83623.34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028724291", 
          "https://doi.org/10.1097/01.wcb.0000033967.83623.34"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1523/jneurosci.4744-14.2015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032212680"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archgenpsychiatry.2009.134", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035316032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.euroneuro.2009.06.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045082804"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/npp.2015.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046703658", 
          "https://doi.org/10.1038/npp.2015.340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/mp.2011.29", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048389439", 
          "https://doi.org/10.1038/mp.2011.29"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10550490902787007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050475933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1220512110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051269526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/npp.2016.265", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051601592", 
          "https://doi.org/10.1038/npp.2016.265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/scan/nsw044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060023786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/ajp.144.9.1184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063477712"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/appi.ajp.163.2.303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063497117"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4088/jcp.v69n0511", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072210207"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-85-6-765", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073734311"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081763545", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083174086", 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-016-2191-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083400133", 
          "https://doi.org/10.1007/s00228-016-2191-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-016-2191-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083400133", 
          "https://doi.org/10.1007/s00228-016-2191-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bph.13812", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084766957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/03007995.2017.1334637", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085616445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/npp.2017.148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090779039", 
          "https://doi.org/10.1038/npp.2017.148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1523/jneurosci.0976-17.2017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090908237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejphar.2018.08.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106019018"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-03-13", 
    "datePublishedReg": "2019-03-13", 
    "description": "Nasal spray formulations of naloxone, a mu-opioid receptor (MOR) antagonist, are currently used for the treatment of opioid overdose. They may have additional therapeutic utility also in the absence of opioid agonist drugs, but the onset and duration of action at brain MORs have been inadequately characterized to allow such projections. This study provides initial characterization of brain MOR availability at high temporal resolution following intranasal (IN) naloxone administration to healthy volunteers in the absence of a competing opioid agonist. Fourteen participants were scanned twice using positron emission tomography (PET) and [11C]carfentanil, a selective MOR agonist radioligand. Concentrations of naloxone in plasma and MOR availability (relative to placebo) were monitored from 0 to 60\u2009min and at 300-360\u2009min post naloxone. Naloxone plasma concentrations peaked at ~20\u2009min post naloxone, associated with slightly delayed development of brain MOR occupancy (half of peak occupancy reached at ~10\u2009min). Estimated peak occupancies were 67 and 85% following 2 and 4\u2009mg IN doses, respectively. The estimated half-life of occupancy disappearance was ~100\u2009min. The rapid onset of brain MOR occupancy by IN naloxone, evidenced by the rapid onset of its action in opioid overdose victims, was directly documented in humans for the first time. The employed high temporal-resolution PET method establishes a model that can be used to predict brain MOR occupancy from plasma naloxone concentrations. IN naloxone may have therapeutic utility in various addictions where brain opioid receptors are implicated, such as gambling disorder and alcohol use disorder.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/s41386-019-0368-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1099176", 
        "issn": [
          "0893-133X", 
          "1740-634X"
        ], 
        "name": "Neuropsychopharmacology", 
        "type": "Periodical"
      }
    ], 
    "name": "Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects", 
    "pagination": "1-7", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d458f92b36f25c3a78f7d3b60c9f85304859f69266db20e1035d16efcc2f1929"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30867551"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8904907"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41386-019-0368-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112734542"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41386-019-0368-x", 
      "https://app.dimensions.ai/details/publication/pub.1112734542"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000364_0000000364/records_72868_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/s41386-019-0368-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41386-019-0368-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41386-019-0368-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41386-019-0368-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41386-019-0368-x'


 

This table displays all metadata directly associated to this object as RDF triples.

294 TRIPLES      21 PREDICATES      65 URIs      18 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41386-019-0368-x schema:about anzsrc-for:11
2 anzsrc-for:1109
3 schema:author Nd92bc0a363b443d397dae737ec1fa433
4 schema:citation sg:pub.10.1007/s00228-016-2191-1
5 sg:pub.10.1007/s00259-008-0935-6
6 sg:pub.10.1038/mp.2011.29
7 sg:pub.10.1038/npp.2015.340
8 sg:pub.10.1038/npp.2016.265
9 sg:pub.10.1038/npp.2017.148
10 sg:pub.10.1038/sj.jcbfm.9600493
11 sg:pub.10.1038/sj.npp.1300790
12 sg:pub.10.1097/01.wcb.0000033967.83623.34
13 sg:pub.10.1097/01.wcb.0000085441.37552.ca
14 https://app.dimensions.ai/details/publication/pub.1081763545
15 https://app.dimensions.ai/details/publication/pub.1083174086
16 https://doi.org/10.1001/archgenpsychiatry.2009.134
17 https://doi.org/10.1001/archpsyc.62.1.57
18 https://doi.org/10.1002/jcph.759
19 https://doi.org/10.1016/j.ejphar.2018.08.004
20 https://doi.org/10.1016/j.euroneuro.2009.06.007
21 https://doi.org/10.1016/j.neuroimage.2005.02.018
22 https://doi.org/10.1016/j.neuroimage.2006.01.021
23 https://doi.org/10.1016/j.neuroimage.2011.07.002
24 https://doi.org/10.1016/s0006-3223(01)01079-4
25 https://doi.org/10.1016/s0140-6736(10)62185-x
26 https://doi.org/10.1016/s0196-0644(83)80343-6
27 https://doi.org/10.1073/pnas.1220512110
28 https://doi.org/10.1080/03007995.2017.1334637
29 https://doi.org/10.1080/10550490902787007
30 https://doi.org/10.1093/scan/nsw044
31 https://doi.org/10.1097/01.wcb.0000085441.37552.ca
32 https://doi.org/10.1111/bph.13812
33 https://doi.org/10.1124/jpet.116.235192
34 https://doi.org/10.1159/000435876
35 https://doi.org/10.1176/ajp.144.9.1184
36 https://doi.org/10.1176/appi.ajp.163.2.303
37 https://doi.org/10.1192/bjp.bp.106.031120
38 https://doi.org/10.1192/bjp.bp.110.078105
39 https://doi.org/10.1523/jneurosci.0976-17.2017
40 https://doi.org/10.1523/jneurosci.4744-14.2015
41 https://doi.org/10.4088/jcp.v69n0511
42 https://doi.org/10.7326/0003-4819-85-6-765
43 schema:datePublished 2019-03-13
44 schema:datePublishedReg 2019-03-13
45 schema:description Nasal spray formulations of naloxone, a mu-opioid receptor (MOR) antagonist, are currently used for the treatment of opioid overdose. They may have additional therapeutic utility also in the absence of opioid agonist drugs, but the onset and duration of action at brain MORs have been inadequately characterized to allow such projections. This study provides initial characterization of brain MOR availability at high temporal resolution following intranasal (IN) naloxone administration to healthy volunteers in the absence of a competing opioid agonist. Fourteen participants were scanned twice using positron emission tomography (PET) and [<sup>11</sup>C]carfentanil, a selective MOR agonist radioligand. Concentrations of naloxone in plasma and MOR availability (relative to placebo) were monitored from 0 to 60 min and at 300-360 min post naloxone. Naloxone plasma concentrations peaked at ~20 min post naloxone, associated with slightly delayed development of brain MOR occupancy (half of peak occupancy reached at ~10 min). Estimated peak occupancies were 67 and 85% following 2 and 4 mg IN doses, respectively. The estimated half-life of occupancy disappearance was ~100 min. The rapid onset of brain MOR occupancy by IN naloxone, evidenced by the rapid onset of its action in opioid overdose victims, was directly documented in humans for the first time. The employed high temporal-resolution PET method establishes a model that can be used to predict brain MOR occupancy from plasma naloxone concentrations. IN naloxone may have therapeutic utility in various addictions where brain opioid receptors are implicated, such as gambling disorder and alcohol use disorder.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree false
49 schema:isPartOf sg:journal.1099176
50 schema:name Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects
51 schema:pagination 1-7
52 schema:productId N4ca131760df54f6cb86ca0c74e4dee62
53 N602a8be49a8b48509480db9dfbf7772f
54 Na53019900935481ca65f7dc41e8ce43f
55 Ne217fed65bc641d18ed91e72f162dfb3
56 Nee0a552b469f41f1b3033799d1e38c14
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112734542
58 https://doi.org/10.1038/s41386-019-0368-x
59 schema:sdDatePublished 2019-04-11T12:55
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher Ne39d65dbb62846c09b92a08b3e5b7c64
62 schema:url https://www.nature.com/articles/s41386-019-0368-x
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N0163b31eb00c4dc29e09fa7600b71c7c schema:affiliation https://www.grid.ac/institutes/grid.470895.7
67 schema:familyName Tuisku
68 schema:givenName Jouni
69 rdf:type schema:Person
70 N02a82a5097d14d0f99136763aeaf49c5 rdf:first N876de2230128409bbce24e2b82e4093d
71 rdf:rest Nb7ee51d137ec45419db566a496a15372
72 N096a1590cf6d4a3980c4c65c8794282d rdf:first N0163b31eb00c4dc29e09fa7600b71c7c
73 rdf:rest N9cfd43d574544e2f86424ffb611cc13b
74 N1bd7f7ad1e96492fb3809bd8d006038e rdf:first N8a9bbcd08c6a44e087588de629ab2b8a
75 rdf:rest N45bc786ebd6441c19f05baed6a991f47
76 N2282f53a78a84f858071f82521c96a6b schema:affiliation https://www.grid.ac/institutes/grid.470895.7
77 schema:familyName Helin
78 schema:givenName Semi
79 rdf:type schema:Person
80 N23cb81bc69c24c14b0aef8baabe4ffe8 schema:affiliation https://www.grid.ac/institutes/grid.410552.7
81 schema:familyName Lovró
82 schema:givenName Zsófia
83 rdf:type schema:Person
84 N4285e6b34c57408ea74d3551ab0d0d45 rdf:first N23cb81bc69c24c14b0aef8baabe4ffe8
85 rdf:rest N02a82a5097d14d0f99136763aeaf49c5
86 N45bc786ebd6441c19f05baed6a991f47 rdf:first N2282f53a78a84f858071f82521c96a6b
87 rdf:rest N096a1590cf6d4a3980c4c65c8794282d
88 N48bb0657d5744911b5f54a77bcb98976 schema:affiliation https://www.grid.ac/institutes/grid.410552.7
89 schema:familyName Vainio
90 schema:givenName Petri J.
91 rdf:type schema:Person
92 N4ca131760df54f6cb86ca0c74e4dee62 schema:name pubmed_id
93 schema:value 30867551
94 rdf:type schema:PropertyValue
95 N54f74a1ed4f74606b0edb02c52986fa9 schema:name Clinical Research Services Turku - CRST Ltd, Turku, Finland
96 rdf:type schema:Organization
97 N602a8be49a8b48509480db9dfbf7772f schema:name nlm_unique_id
98 schema:value 8904907
99 rdf:type schema:PropertyValue
100 N63a43149c7224a6e9badd40a9c53b5d3 rdf:first N9e809e1858a64c1d9e5c02c6b3eaf743
101 rdf:rest N76530a43b18d458cb58d73391a48459d
102 N6e2c18ed420d4bcea659c76fc63aeb53 schema:affiliation https://www.grid.ac/institutes/grid.12650.30
103 schema:familyName Johansson
104 schema:givenName Jarkko
105 rdf:type schema:Person
106 N76530a43b18d458cb58d73391a48459d rdf:first Nc8cb8c0b54244b9990ba6ef36a6e9ac9
107 rdf:rest Nd0ebfc6889534afda6c20efc97bea3a1
108 N7772e2902b884671a784da25315d974b schema:affiliation https://www.grid.ac/institutes/grid.1374.1
109 schema:familyName Hirvonen
110 schema:givenName Jussi
111 rdf:type schema:Person
112 N77c40dc1d96a4ccf97bb1006f9b68367 schema:name Opiant Pharmaceuticals Inc., Santa Monica, CA, USA
113 rdf:type schema:Organization
114 N81a6ba381377467ea100c8da9a223335 schema:affiliation https://www.grid.ac/institutes/grid.410552.7
115 schema:familyName Scheinin
116 schema:givenName Mika
117 rdf:type schema:Person
118 N8540e6b810e44ab593aa681eaa25d0d0 schema:affiliation https://www.grid.ac/institutes/grid.410552.7
119 schema:familyName Sirén
120 schema:givenName Saija
121 rdf:type schema:Person
122 N876de2230128409bbce24e2b82e4093d schema:affiliation https://www.grid.ac/institutes/grid.470895.7
123 schema:familyName Ekblad
124 schema:givenName Laura
125 rdf:type schema:Person
126 N8a9bbcd08c6a44e087588de629ab2b8a schema:affiliation https://www.grid.ac/institutes/grid.410552.7
127 schema:familyName Rajasilta
128 schema:givenName Olli
129 rdf:type schema:Person
130 N997ddda983b647b8952a022a9c6ddb3d schema:affiliation https://www.grid.ac/institutes/grid.410552.7
131 schema:familyName Kaasinen
132 schema:givenName Valtteri
133 rdf:type schema:Person
134 N99fcc29a5741454793993475cac29367 rdf:first N81a6ba381377467ea100c8da9a223335
135 rdf:rest rdf:nil
136 N9cfd43d574544e2f86424ffb611cc13b rdf:first N8540e6b810e44ab593aa681eaa25d0d0
137 rdf:rest Nb87426a6716f4ea7bcae6273f7735de6
138 N9e809e1858a64c1d9e5c02c6b3eaf743 schema:affiliation N77c40dc1d96a4ccf97bb1006f9b68367
139 schema:familyName Agrawal
140 schema:givenName Arvind
141 rdf:type schema:Person
142 Na33820d712854d279a9b2371ffe28408 rdf:first Nad7785b977cf4a04b5b34abc54a5c7b2
143 rdf:rest N99fcc29a5741454793993475cac29367
144 Na53019900935481ca65f7dc41e8ce43f schema:name readcube_id
145 schema:value d458f92b36f25c3a78f7d3b60c9f85304859f69266db20e1035d16efcc2f1929
146 rdf:type schema:PropertyValue
147 Nad7785b977cf4a04b5b34abc54a5c7b2 schema:affiliation https://www.grid.ac/institutes/grid.15485.3d
148 schema:familyName Alho
149 schema:givenName Hannu
150 rdf:type schema:Person
151 Nb7ee51d137ec45419db566a496a15372 rdf:first N997ddda983b647b8952a022a9c6ddb3d
152 rdf:rest N1bd7f7ad1e96492fb3809bd8d006038e
153 Nb87426a6716f4ea7bcae6273f7735de6 rdf:first Nf7691c919b4248c8a51a44da8d6e40a5
154 rdf:rest N63a43149c7224a6e9badd40a9c53b5d3
155 Nc8cb8c0b54244b9990ba6ef36a6e9ac9 schema:affiliation Nca41e9604e974efab8c6ac763728f2c6
156 schema:familyName Crystal
157 schema:givenName Roger
158 rdf:type schema:Person
159 Nca41e9604e974efab8c6ac763728f2c6 schema:name Opiant Pharmaceuticals Inc., Santa Monica, CA, USA
160 rdf:type schema:Organization
161 Nd0ebfc6889534afda6c20efc97bea3a1 rdf:first N48bb0657d5744911b5f54a77bcb98976
162 rdf:rest Na33820d712854d279a9b2371ffe28408
163 Nd92bc0a363b443d397dae737ec1fa433 rdf:first N6e2c18ed420d4bcea659c76fc63aeb53
164 rdf:rest Nf878ff99e0de48e9b4c1e0c67bb4b1d1
165 Ne217fed65bc641d18ed91e72f162dfb3 schema:name dimensions_id
166 schema:value pub.1112734542
167 rdf:type schema:PropertyValue
168 Ne39d65dbb62846c09b92a08b3e5b7c64 schema:name Springer Nature - SN SciGraph project
169 rdf:type schema:Organization
170 Nee0a552b469f41f1b3033799d1e38c14 schema:name doi
171 schema:value 10.1038/s41386-019-0368-x
172 rdf:type schema:PropertyValue
173 Nf7691c919b4248c8a51a44da8d6e40a5 schema:affiliation N54f74a1ed4f74606b0edb02c52986fa9
174 schema:familyName Pennanen
175 schema:givenName Mirka
176 rdf:type schema:Person
177 Nf878ff99e0de48e9b4c1e0c67bb4b1d1 rdf:first N7772e2902b884671a784da25315d974b
178 rdf:rest N4285e6b34c57408ea74d3551ab0d0d45
179 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
180 schema:name Medical and Health Sciences
181 rdf:type schema:DefinedTerm
182 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
183 schema:name Neurosciences
184 rdf:type schema:DefinedTerm
185 sg:journal.1099176 schema:issn 0893-133X
186 1740-634X
187 schema:name Neuropsychopharmacology
188 rdf:type schema:Periodical
189 sg:pub.10.1007/s00228-016-2191-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083400133
190 https://doi.org/10.1007/s00228-016-2191-1
191 rdf:type schema:CreativeWork
192 sg:pub.10.1007/s00259-008-0935-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026801956
193 https://doi.org/10.1007/s00259-008-0935-6
194 rdf:type schema:CreativeWork
195 sg:pub.10.1038/mp.2011.29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048389439
196 https://doi.org/10.1038/mp.2011.29
197 rdf:type schema:CreativeWork
198 sg:pub.10.1038/npp.2015.340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046703658
199 https://doi.org/10.1038/npp.2015.340
200 rdf:type schema:CreativeWork
201 sg:pub.10.1038/npp.2016.265 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051601592
202 https://doi.org/10.1038/npp.2016.265
203 rdf:type schema:CreativeWork
204 sg:pub.10.1038/npp.2017.148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090779039
205 https://doi.org/10.1038/npp.2017.148
206 rdf:type schema:CreativeWork
207 sg:pub.10.1038/sj.jcbfm.9600493 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027459113
208 https://doi.org/10.1038/sj.jcbfm.9600493
209 rdf:type schema:CreativeWork
210 sg:pub.10.1038/sj.npp.1300790 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016493335
211 https://doi.org/10.1038/sj.npp.1300790
212 rdf:type schema:CreativeWork
213 sg:pub.10.1097/01.wcb.0000033967.83623.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028724291
214 https://doi.org/10.1097/01.wcb.0000033967.83623.34
215 rdf:type schema:CreativeWork
216 sg:pub.10.1097/01.wcb.0000085441.37552.ca schema:sameAs https://app.dimensions.ai/details/publication/pub.1002335609
217 https://doi.org/10.1097/01.wcb.0000085441.37552.ca
218 rdf:type schema:CreativeWork
219 https://app.dimensions.ai/details/publication/pub.1081763545 schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1083174086 schema:CreativeWork
221 https://doi.org/10.1001/archgenpsychiatry.2009.134 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035316032
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1001/archpsyc.62.1.57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006003582
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1002/jcph.759 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005050213
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/j.ejphar.2018.08.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106019018
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/j.euroneuro.2009.06.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045082804
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1016/j.neuroimage.2005.02.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028354406
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/j.neuroimage.2006.01.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005818793
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/j.neuroimage.2011.07.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010720015
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/s0006-3223(01)01079-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021383326
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1016/s0140-6736(10)62185-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1017818959
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/s0196-0644(83)80343-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022544717
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1073/pnas.1220512110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051269526
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1080/03007995.2017.1334637 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085616445
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1080/10550490902787007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050475933
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1093/scan/nsw044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060023786
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1097/01.wcb.0000085441.37552.ca schema:sameAs https://app.dimensions.ai/details/publication/pub.1002335609
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1111/bph.13812 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084766957
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1124/jpet.116.235192 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018917259
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1159/000435876 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027499237
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1176/ajp.144.9.1184 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063477712
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1176/appi.ajp.163.2.303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063497117
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1192/bjp.bp.106.031120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008044803
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1192/bjp.bp.110.078105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024901521
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1523/jneurosci.0976-17.2017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090908237
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1523/jneurosci.4744-14.2015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032212680
270 rdf:type schema:CreativeWork
271 https://doi.org/10.4088/jcp.v69n0511 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072210207
272 rdf:type schema:CreativeWork
273 https://doi.org/10.7326/0003-4819-85-6-765 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073734311
274 rdf:type schema:CreativeWork
275 https://www.grid.ac/institutes/grid.12650.30 schema:alternateName Umeå University
276 schema:name Department of Radiation Sciences, Umeå University, Umeå, Sweden
277 Turku PET Centre, University of Turku, Turku, Finland
278 rdf:type schema:Organization
279 https://www.grid.ac/institutes/grid.1374.1 schema:alternateName University of Turku
280 schema:name Department of Radiology, University of Turku, Turku, Finland
281 Turku PET Centre, University of Turku, Turku, Finland
282 rdf:type schema:Organization
283 https://www.grid.ac/institutes/grid.15485.3d schema:alternateName Helsinki University Central Hospital
284 schema:name Abdominal Center, University Hospital of Helsinki, Helsinki, Finland
285 National Institute for Health and Welfare, Helsinki, Finland
286 rdf:type schema:Organization
287 https://www.grid.ac/institutes/grid.410552.7 schema:alternateName Turku University Hospital
288 schema:name Clinical Research Services Turku - CRST Ltd, Turku, Finland
289 Division of Clinical Neurosciences, University of Turku and Turku University Hospital, Turku, Finland
290 Institute of Biomedicine, University of Turku and Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland
291 rdf:type schema:Organization
292 https://www.grid.ac/institutes/grid.470895.7 schema:alternateName Turku PET Centre
293 schema:name Turku PET Centre, University of Turku, Turku, Finland
294 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...